Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database

ConclusionThe present analysis showed adverse events of abobotulinumtoxinA were significantly associated with overdose versus the other two BtxA agents. Overdose can be difficult to research, particularly for in-clinic administered drugs. Future studies should venture to confirm these results in new and novel ways.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research